Consolidated Unaudited Interim Report of AS PRFoods for the 2nd quarter and 6 months of 2020/2021 financial year



Second half of 2020 is characterized by continuation of COVID crisis. Salmon prices are 12-year low and compared to the same period last year, salmon prices are down 38% and rainbow trout is down by 22.5%. Adding to this global decrease in demand due to shutdown of HoReCa and you can call the situation as „perfect storm“. Companies who emerge from this crisis unscathed will be future winners. Arrival of vaccines is giving hope that we can see some normalization during 2nd half of 2021. 2022 will definitely be more profitable year in Fish farming as farmers can plan better the demand. Today’s farming volumes were planned before crisis and therefore there is massive oversupply in the market and most Fish farmers operate either at loss or at break-even. John Ross Jr has shown extraordinary resilience in current crisis and is forecasted to end current financial year with similar result as to year before, gross margin of the business has risen over 50%. Estonian operations and cost base has been adjusted to the changed market situation. Unfortunately we cannot say the same about Finland and we plan to carry out significant restructuring of Finnish business during Q1.

The group ended Q4 already in profit, but due to significantly lower sales, our operational EBITDA margin was 3.4% compared to 8.4% year before (consolidated EBITDA margin 4.1% and 5.3% accordingly). Production cost base cannot be adjusted to such drastic market changes without bigger restructuring. Yet we have managed to decrease costs in Finnish unit by 75,000 euros per month from beginning of the year and see further avenues for decreasing costs. At the same time we cannot ignore the fact that sales need to be recovered, particularly in Finland.

The focus in the beginning of the year is to adjust cost base to the market situation, improving liquidity of the business and larger focus in Baltics and Scandinavia on Fish farming which continues to be the most promising area in business. John Ross Jr has adjusted extremely well to the crisis and despite loss of some sales in first 6 months of current financial year, has increased its profitability due to lower raw material prices.

Thanks to lower cost base, we believe, that we will finish 2020/2021 II half and entire financial year with positive EBITDA.



mln EUR4Q 20203Q 20202Q 20201Q 20204Q 20193Q 20192Q 20191Q 2019
Gross profit2.
EBITDA from operations0.6-0.3-
Net profit (-loss)-0.2-1.4-1.3-
Gross margin14.9%9.4%4.6%10.8%17.0%13.4%9.8%11.7%
Operational EBITDA margin3.4%-2.6%-2.6%0.1%8.4%3.8%1.4%1.1%
EBITDA margin4.1%-3.8%-2.6%-4.6%5.3%7.6%1.4%-2.5%
EBIT margin0.2%-8.8%-6.4%-7.8%2.9%5.0%-1.2%-5.6%
EBT margin-0.6%-11.3%-8.1%-9.8%2.2%3.9%-2.0%-6.5%
Net margin-1.2%-11.3%-8.4%-9.2%2.0%2.9%-3.0%-6.6%
Operating expense ratio15.6%18.2%13.9%14.3%12.5%13.4%11.7%14.1%


mln EUR31.12.202030.09.202030.06.202031.03.202031.12.201930.09.2019 30.06.2019
Net debt21.921.520.717.017.819.920.5
Working capital-3.9-4.4-4.0-2.5-3.5-3.0-3.1
Liquidity ratio0.8x0.8x0.8x0.9x0.9x0.9x0.9x
Equity ratio32.4%32.3%34.7%37.9%38.5%36.5%35.0%
Gearing ratio54.0%53.7%51.1%44.0%43.3%46.6%48.3%
Debt to total assets0.7x0.7x0.7x0.6x0.6x0.6x0.7x
Net debt to EBITDA op160.0x12.8x7.5x5.3x5.3x5.4x5.1x

Consolidated Statement of Financial Position

Thousand euros31.12.202031.12.201930.06.2020
Cash and cash equivalents9622 6802 276
Receivables and prepayments4,1536,3423,578
Biological assets3,7024,3544,249
Total current assets18,44422,48017,987
Deferred income tax216654
Long-term financial investments232217232
Tangible fixed assets15,96814,44416,179
Intangible assets22,84123,28622,672
Total non-current assets39,06238,01339,137
TOTAL ASSETS57,50660,49357,124
Loans and borrowings9,63412,50510,611
Government grants212188211
Total current liabilities22,31525,99421,954
Loans and borrowings13,2547,94512,368
Deferred tax liabilities1,9122,0701,920
Government grants785981873
Total non-current liabilities16,54711,18615,351
TOTAL LIABILITIES38,86237,18037,305
Share capital7,7377,7377,737
Share premium14,19714,00714,007
Treasury shares-390-390-390
Statutory capital reserve515151
Currency translation reserve-98167-366
Retained profit (-loss)-3,2461,108-1,654
Equity attributable to parent18,25222,68019,385
Non-controlling interest392633434
TOTAL EQUITY18,64423,31319,819

Consolidated Statement of Profit or Loss And Other Comprehensive Income

Thousand euros2Q 2020/20212Q 2019/20206 months 2020/20216 months 2019/2020
Cost of goods sold-14,496-21,049-26,033-37,796
Gross profit2,5334,3253,7336,907
Operating expenses-2,663-3,169-4,985-5,767
Selling and distribution expenses-1,809-2,146-3,367-3,938
Administrative expenses-854-1,023-1,618-1,829
Other income / expense46206137334
Fair value adjustment on biological assets118-62224224
Operating profit (loss)34740-1,0911,698
Financial income/-expenses-129-190-438-393
Profit (loss) before tax-95550-1,5291,305
Income tax-101-54-105-239
Net profit (loss) for the period-196496-1,6341,066
Net profit (loss) attributable to:
Owners of the company-190529-1,5921,042
Non-controlling interests-6-33-4224
Total net profit (loss)-196496-1,6341,066
Other omprehensive income (loss) that may subsequently be classified to profit or loss:
Foreign currency translation differences16966268381
Total comprehensive income (expense)-27562-1,3661,447
Total comprehensive income (expense) attributable to:
Owners of the Company-21595-1,3241,423
Non-controlling interests-6-33-4224
Total comprehensive income (expense) for the period-27562-1,3661,447
Profit (loss) per share (EUR)0.000.01-0.040.03
Diluted profit (loss) per share (EUR)0.000.01-0.040.03

Indrek Kasela

AS PRFoods

Member of the Management Board

Phone:+372 452 1470


About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Better Collective – Share buyback program completed5.3.2021 19:30:00 CETPress release

Regulatory Release 4/2021 On March 4, 2021 Better Collective A/S initiated a share buyback program for up to EUR 100,000, to be executed during the period from March 4, 2021 to March 31, 2021. The following transactions have been executed under the program on March 5, 2021 Date Number of sharesAverage weighted purchase price (SEK per share)Amount (SEK)05/03/20213,532197.2223696,598.16Accumulated under the program following above purchase:3,532197.2223696,598.16 Better Collective A/S holds 3,773 treasury shares corresponding to 0,01 % of the outstanding share capital of the company. The share buyback program is hereby completed. Contacts Investor Relations: Christina Bastius Thomsen +45 2363 8844 e-mail: This information is such information as Better Collective A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on March 5, 2021 at 7.3

TGS Share Repurchase5.3.2021 17:51:25 CETPress release

Oslo, Norway (5 March 2021) – On period from 2 March 2021 to 4 March 2021, TGS-NOPEC Geophysical Company ASA (TGS) purchased 41,000 own shares on the Oslo Stock Exchange at an average price of NOK 141.2252 per share. Following the purchase, TGS holds 195,000 own shares, representing 0.166% of the total outstanding shares. The shares were purchased in connection with the share repurchase announced on 11 February 2021. Overview of transactionsDateAggregated daily volume (number of shares)Weighted average share price per day (NOK)Total daily transaction value (NOK)2-Mar-2120,000140.90672,818,1343-Mar-2120,000141.57002,831,4004-Mar-211,000140.7000140,700Previously disclosed buy-backs under the program (accumulated)79,000138.327910,927,901Accumulated under the buy-back program120,000139.317816,718,135The issuer's holding of own shares:Following the completion of the above transactions, TGS owns a total of 195,000 own shares, corresponding to 0.166% of TGS' share capital.Appendix:An overview

Bavarian Nordic to Host Full Year 2020 Results Conference Call5.3.2021 17:30:00 CETPress release

COPENHAGEN, Denmark – March 5, 2021 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) will announce its 2020 annual report on Friday, March 12, 2021. The management of Bavarian Nordic will host a conference call at 2:00 pm CET (8:00 am EST) on the same day to present the full-year results followed by a Q&A session. A live and replay version of the call and relevant slides will be available at To join the Q&A session dial one of the following numbers and state the participant code 5589045: Denmark: +45 32 72 80 42, UK: +44 (0) 844 571 8892, USA: +1 631-510-7495. About Bavarian Nordic Bavarian Nordic is a fully integrated vaccines company focused on the development, manufacture and commercialization of life-saving vaccines. We are a global leader in smallpox vaccines and have been a long-term supplier to the U.S. Strategic National Stockpile of a non-replicating smallpox vaccine, which has been approved by the FDA under the trade name JYNNEOS®, also for the protection

Bavarian Nordic afholder telefonkonference i forbindelse med offentliggørelse af årsregnskabet for 20205.3.2021 17:30:00 CETpressemeddelelse

KØBENHAVN, 5. marts 2021 – Bavarian Nordic A/S (OMX: BAVA) offentliggør årsregnskab for 2020 på fredag den 12. marts 2021. Samme dag afholder selskabets ledelse en telefonkonference kl. 14:00 dansk tid med henblik på at præsentere årsregnskabet og besvare eventuelle spørgsmål. Det er muligt at høre en live eller arkiveret webcast af telefonkonferencen samt downloade den tilhørende præsentation på For at stille spørgsmål på telefonkonferencen, benyt venligst et af følgende telefonnumre og oplys deltagerkoden 5589045: Danmark: +45 32 72 80 42, UK: +44 (0) 844 571 8892, USA: +1 631-510-7495. Om Bavarian Nordic Bavarian Nordic er et fuldt integreret vaccineselskab, der er fokuseret på udvikling, produktion og kommercialisering af livsvigtige vacciner. Vi er globalt førende inden for koppevacciner, og er mangeårig leverandør til det amerikanske strategiske nationale beredskabslager af en ikke-replikerende koppevaccine, som er godkendt af de amerikanske sundhedsmyndigh


Almere, The Netherlands March 5, 2021 ASM International N.V. (Euronext Amsterdam: ASM) today publishes its Annual Report 2020. For the first time, ASMI publishes the Annual Report in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (xHTML). In line with the ESEF requirements, the primary consolidated financial statements have been labelled with XBRL tags. ASMI's Annual Report 2020 is available in ESEF reporting package, HTML file and as a PDF file on the company's website ASMI will hold its Annual General Meeting of Shareholders (AGM) on May 17, 2021. The AGM agenda with all related documents will be available in due time. About ASM International ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and pa


Anbudsförfarande kommuner och regioner, 2021-03-09BondsFixed rate notes issued in SEK by Municipalities or Regions with maturity in: 2024 The following issuers are accepted for delivery: Göteborgs Stad Helsingborgs Stad Jönköpings Kommun Malmö Stad Region Skåne Stockholms Stad Region Stockholm Delivery may not be made in Bonds purchased by the Counterparty from the issuer less than one week prior to the date for announcing the Specific terms, i.e. the purchase may not have been made after: 2021-02-26BidsBids are made to tel 08-696 69 70 and confirmed in writing by a filled-in Bid form by e-mail to Bid date2021-03-09Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SEK 1000 +/- 1000 millionHighest permitted bid volume (corresponding nominal amount)The total bid volume from one Counterparty for the two Credit rating classes may not exceed SEK 1 000 million. No bid may contain Bonds exceeding SEK 1000 million issued by Stockholms


Bid procedure, 2021-03-08BillsSWEDISH T-BILL: SE0015504907. 2021-05-19 SWEDISH T-BILL: SE0014808747, 2021-09-15 Bid date2021-03-08Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)SE0015504907: 500 mln SEK +/-250 mln SEK SE0014808747: 500 mln SEK +/-250 mln SEK Highest permitted bid volume (corresponding nominal amount)SE0015504907: 500 mln SEK per bid SE0014808747: 500 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2021-03-10Delivery of billsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2021-03-05 This is a translation of the special terms and conditions published on In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and